FDA safety alert over radiofrequency ablation
This article was originally published in Clinica
Executive Summary
MedWatch, the US FDA's reporting system for adverse events, has issued a warning over use of radiofrequency (RF) ablation devices. The warning follows reports of patient deaths associated with the use of RF during lung tumour ablation.